Hemostatic

In January, Traumagel, a plant-based hemostatic gel that controls bleeding in seconds when applied to a wound at the point of care, saw its commercial release in the United States.

The FDA has granted 510(k) clearance to a plant-based, hemostatic gel to treat moderate to severe bleeding, according to the manufacturer.

A Brooklyn-based biotech firm has announced successful completion of the first phase of a preclinical study conducted with the Walter Reed Army Institute of Research involving a proprietary hemostatic hydrogel to treat traumatic brain injury.

KOAG LLC, a Minneapolis-based medical device firm, announced it received FDA clearance for its topical vascular closure system.